Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.

Abstract:

BACKGROUND:Nasopharyngeal carcinoma (NPC) is associated closely with Epstein-Barr virus (EBV). The authors previously reported that an EBV immediate-early gene, BRLF1, was expressed frequently in NPC tumors, and a significant elevation in immunoglobulin G (IgG) antibodies directed against BRLF1 gene product Rta was detected in NPC sera by a radioactive immunoprecipitation assay. To simplify and to make the detection more quantitative, an enzyme-linked immnunosorbent assay (ELISA) was developed in this study. METHODS:Antigen domains of Rta were identified further using an immunoprecipitation assay. Two glutathione-S-transferase (GST) recombinant Rta fragments (R150-GST and R185-GST) were prepared subsequently and were used as antigens in the ELISA. Serum samples derived from 51 patients with NPC patients, 115 non-NPC ENT patients, and 47 healthy volunteers were examined for the presence of antibodies directed against Rta. RESULTS:Among the patients with NPC, 74.5% showed a positive IgG response to R150-GST, and 62.7% showed a positive IgG response to R185-GST, with 80.4% positive for either fragment. In contrast, the reactions were positive in only 8.5% of healthy volunteers and 13.0% of control patients. When using a mixture of the two recombinant Rta proteins as coating antigens, the IgG positive responses were 82.3%, 10.6%, and 14.8%, respectively, in patients with NPC, healthy volunteers, and control patients. It is noteworthy that 51.0% of the NPC sera showed a positive immunoglobulin A (IgA) response, with none of the control patients showing obvious reactivity. Both the IgG response and the IgA response to Rta protein in patients with NPC were correlated with the IgA response to EBV early antigens and virus capsid antigens, the classic serologic markers used to diagnose NPC. CONCLUSIONS:The ELISA method described for the detection of IgG antibodies directed against recombinant Rta proteins is simple and reliable and may be useful as a serologic parameter for the screening and diagnosis of patients with NPC.

journal_name

Cancer

journal_title

Cancer

authors

Feng P,Chan SH,Soo MY,Liu D,Guan M,Ren EC,Hu H

doi

10.1002/1097-0142(20011001)92:7<1872::aid-cncr1704

subject

Has Abstract

pub_date

2001-10-01 00:00:00

pages

1872-80

issue

7

eissn

0008-543X

issn

1097-0142

pii

10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704

journal_volume

92

pub_type

杂志文章

相关文献

CANCER文献大全
  • Nephrotoxicity of nitrosoureas.

    abstract::Irreversible and progressive renal parenchymal damage and functional impairment occurred in the majority of patients receiving at least six courses (200 mg/m2 of BCNU and/or methyl CCNU at eight-week intervals) of nitrosoureas for therapy of malignant brain tumors. Seventeen of 18 patients who received at least six co...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810915)48:6<1328::aid-cncr2820

    authors: Schacht RG,Feiner HD,Gallo GR,Lieberman A,Baldwin DS

    更新日期:1981-09-15 00:00:00

  • Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.

    abstract:BACKGROUND:The authors evaluated the efficacy of adjuvant chemotherapy with 5-fluorouracil (5-FU) plus doxorubicin in gastric carcinoma after D2-3 curative resection. They also evaluated the effect of dose-related factors (delivered total dose/m(2), actual dose intensity [ADI], relative dose intensity [RDI]) of this re...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20010601)91:11<2016::aid-cncr122

    authors: Jeung HC,Rha SY,Noh SH,Min JS,Kim BS,Chung HC

    更新日期:2001-06-01 00:00:00

  • Efficacy of follow-up bone scans in carcinoma of the prostate.

    abstract::Three hundred fifteen radioisotopic bone scans ranging from initial scan only to nine scans per patient, performed on 114 patients with adenocarcinoma of the prostate between 1979 and 1984, were reviewed. Seventeen patients had positive scans, ten on initial scan and seven at follow-up. Nine patients had bone pain at ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880615)61:12<2453::aid-cncr282

    authors: Corrie D,Timmons JH,Bauman JM,Thompson IM

    更新日期:1988-06-15 00:00:00

  • Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.

    abstract:BACKGROUND:Poor accrual to cancer clinical trials may contribute to the lower improvement in survival observed for adolescents and young adults (AYAs) (those aged 15-39 years) with cancer. This has been difficult to quantify without reliable mechanisms to link incident cases with study enrollments. Using unique resourc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29669

    authors: Collins CL,Malvar J,Hamilton AS,Deapen DM,Freyer DR

    更新日期:2015-12-15 00:00:00

  • Influence of oral contraceptives on the prognosis of breast cancer in young women.

    abstract::The possible effect of oral contraceptive (OC) use on the prognosis of established breast cancer was investigated in 154 young women aged 35 and younger. No significant differences were found between the study group of 59 OC users, and the control group of 95 nonusers in age, parity and gravidity, family history of br...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850401)55:7<1556::aid-cncr2820

    authors: Rosner D,Lane WW,Perez Brett R

    更新日期:1985-04-01 00:00:00

  • A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

    abstract:BACKGROUND:Treatment with traditional cytotoxic chemotherapy regimens containing streptozocin or dacarbazine has resulted in only marginal benefit for patients with metastatic neuroendocrine tumors. The use of these regimens has been further limited by their potential toxicity. Gemcitabine is generally well tolerated a...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.20466

    authors: Kulke MH,Kim H,Clark JW,Enzinger PC,Lynch TJ,Morgan JA,Vincitore M,Michelini A,Fuchs CS

    更新日期:2004-09-01 00:00:00

  • Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study.

    abstract:BACKGROUND:Social needs may affect cancer survivors' health-related quality of life (HRQOL) above and beyond sociodemographic and cancer-related factors. The purpose of this study was to estimate associations between social needs and HRQOL. METHODS:Results included data from 1754 participants in the Detroit Research o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33286

    authors: Hastert TA,McDougall JA,Strayhorn SM,Nair M,Beebe-Dimmer JL,Schwartz AG

    更新日期:2021-02-01 00:00:00

  • Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.

    abstract:BACKGROUND:Children diagnosed with medulloblastoma whose tumor involves the brain stem or has spread through the cerebrospinal fluid pathways to other areas of the brain or spinal cord have a poor prognosis despite therapy with surgery, craniospinal irradiation (CSI), and chemotherapy. Preradiation chemotherapy may imp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931101)72:9<2755::aid-cncr2820

    authors: Mosijczuk AD,Nigro MA,Thomas PR,Burger PC,Krischer JP,Morantz RA,Kurdunowicz B,Mulne AF,Towbin RB,Freeman AI

    更新日期:1993-11-01 00:00:00

  • Turcot's syndrome. Flow cytometric analysis.

    abstract::Turcot's syndrome is a rare, genetically transmittable disease in which patients with colonic polyposis (possibly complicated by the progression to adenocarcinoma) have malignant central nervous system neoplasms. Dominant, recessive, and sporadic cases have been described. A 26-year-old man is reported with no relevan...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19911001)68:7<1633::aid-cncr2820

    authors: Newton HB,Rosenblum MK,Malkin MG

    更新日期:1991-10-01 00:00:00

  • Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.

    abstract:BACKGROUND:Germ cell tumors (GCTs) in adolescent and young males are very sensitive to cisplatin-based chemotherapy. However, 10-20% of the patients cannot be cured by currently available therapeutic options. Once a tumor does not respond to cisplatin, current therapeutic modalities offer only a chance for short pallia...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10671

    authors: Kollmannsberger C,Mayer F,Pressler H,Koch S,Kanz L,Oosterhuis JW,Looijenga LH,Bokemeyer C

    更新日期:2002-07-15 00:00:00

  • Clinical evaluation of specific gamma-GTP isoenzyme in patients with hepatocellular carcinoma.

    abstract::The authors evaluated specific gamma-GTP isoenzyme (specific gamma-GTP) found in sera of patients with hepatocellular carcinoma (HCC). In addition to band II and II' which had been reported in our previous publication, band I' also had a high specificity for HCC. One or more of these bands were detectable in 109 (55%)...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830115)51:2<327::aid-cncr28205

    authors: Sawabu N,Nakagen M,Ozaki K,Wakabayashi T,Toya D,Hattori N,Ishii M

    更新日期:1983-01-15 00:00:00

  • A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma.

    abstract::The mechanisms of biochemical modulation of 5-fluorouracil (5-FU) cytotoxicity by folinic acid (FA) have been elucidated, and the clinical use of this combination has improved response rates and survival in patients with metastatic colorectal cancer. Recently, Phase II trials also showed potential synergism between al...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19920215)69:4<889::aid-cncr28206

    authors: Bukowski RM,Inoshita G,Yalavarthi P,Murthy S,Gibson V,Budd GT,Sergi JS,Bauer L,Prestifilippo J

    更新日期:1992-02-15 00:00:00

  • Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion.

    abstract:BACKGROUND:The objective of the current study was to correlate pretreatment computed tomography and magnetic resonance imaging studies with outcomes for patients with squamous or basal cell carcinoma of the skin and clinical perineural invasion. METHODS:Between 1986 and 2002, 45 patients were treated with radiotherapy...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20913

    authors: Galloway TJ,Morris CG,Mancuso AA,Amdur RJ,Mendenhall WM

    更新日期:2005-03-15 00:00:00

  • JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

    abstract:BACKGROUND:A somatic gain-of-function mutation of the Janus kinase 2 (JAK2) gene has been identified in chronic myeloproliferative disorders, which appear to have a sporadic occurrence in most individuals. The authors studied the biologic significance of the JAK2 (V617F) mutation in familial myeloproliferative disorder...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22240

    authors: Rumi E,Passamonti F,Pietra D,Della Porta MG,Arcaini L,Boggi S,Elena C,Boveri E,Pascutto C,Lazzarino M,Cazzola M

    更新日期:2006-11-01 00:00:00

  • The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

    abstract::Over the last decade, new cytotoxic treatments and targeted therapies have altered treatment paradigms for patients with metastatic non-small cell lung cancer (NSCLC). We sought to analyze the impact of histology and biomarker selection criteria on outcomes of clinical trials in metastatic NSCLC reported over the last...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28956

    authors: Gentzler RD,Yentz SE,Johnson ML,Rademaker AW,Patel JD

    更新日期:2014-12-15 00:00:00

  • Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.

    abstract:BACKGROUND:The current study determined the efficacy and toxicity of weekly paclitaxel in combination with estramustine phosphate (EMP) in patients with androgen-independent prostate carcinoma (AIPC). METHODS:Patients with progressive AIPC received 90 mg/m2 paclitaxel by 1-hour intravenous infusion weekly for 3 weeks,...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.11956

    authors: Vaughn DJ,Brown AW Jr,Harker WG,Huh S,Miller L,Rinaldi D,Kabbinavar F

    更新日期:2004-02-15 00:00:00

  • Disposition of high-dose methotrexate in an obese cancer patient.

    abstract::The disposition of many drugs in obesity is altered, although little is known of the effect of obesity on the pharmacokinetics of anti-cancer drugs. In this report the authors describe the pharmacokinetics of high-dose methotrexate in an obese woman (184% ideal body weight) with osteosarcoma. For this patient, both th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910915)68:6<1247::aid-cncr2820

    authors: Fleming RA,Eldridge RM,Johnson CE,Stewart CF

    更新日期:1991-09-15 00:00:00

  • The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia.

    abstract:BACKGROUND:Patients with chronic lymphocytic leukemia (CLL) that transforms to Richter syndrome (RS) frequently show atypical lymphocytes in bone marrow; however, a diagnosis of RS requires confirmation of the presence of sheets of large cells in bone marrow or lymph nodes. METHODS:In this study, the authors evaluated...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20251

    authors: Ma Y,Mansour A,Bekele BN,Zhou X,Keating MJ,O'Brien S,Giles FJ,Albitar M

    更新日期:2004-05-15 00:00:00

  • Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.

    abstract::Twenty-eight peritoneovenous shunts were placed to relieve ascites in 26 patients with a variety of underlying malignancies. Nine of the patients had documented liver metastases and hyperbilirubinemia. Severe thrombocytopenia with laboratory evidence of disseminated intravascular coagulation (DIC) occurred in four of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850601)55:11<2718::aid-cncr282

    authors: Tempero MA,Davis RB,Reed E,Edney J

    更新日期:1985-06-01 00:00:00

  • Acquired myeloperoxidase deficiency and recurrent infections in a patient with acute myelomonocytic leukemia.

    abstract::Acquired myeloperoxidase deficiency has been reported in several hematological malignancies. The clinical course of a patient with acute myelomonocytic leukemia is described which was characterized by staphylococcal infections prior to therapy and again during a period of relapse. Neutropenia was not a feature of thes...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197912)44:6<2244::aid-cncr282044

    authors: Kitahara M,Kushner JP

    更新日期:1979-12-01 00:00:00

  • A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.

    abstract:BACKGROUND:Outcomes for patients with relapsed/refractory acute myeloid leukemia (R/R AML) remain poor. Novel therapies specifically targeting AML are of high interest. Brentuximab vedotin (BV) is an antibody-drug conjugate that is specific for human CD30. In this phase 1 dose escalation study, the authors evaluated th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32657

    authors: Narayan R,Blonquist TM,Emadi A,Hasserjian RP,Burke M,Lescinskas C,Neuberg DS,Brunner AM,Hobbs G,Hock H,McAfee SL,Chen YB,Attar E,Graubert TA,Bertoli C,Moran JA,Bergeron MK,Foster JE,Ramos AY,Som TT,Vartanian MK,

    更新日期:2020-03-15 00:00:00

  • Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.

    abstract:BACKGROUND:The combination of paclitaxel with cisplatin or carboplatin has become the preferred chemotherapy regimen in the treatment of epithelial ovarian carcinoma. Anthracyclines also have activity in this disease. We conducted a Phase II study by using the combination of paclitaxel, cisplatin, and epirubicin for th...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3

    authors: Papadimitriou CA,Moulopoulos LA,Vlahos G,Voulgaris Z,Kiosses E,Georgoulias N,Gika D,Diakomanolis E,Michalas S,Dimopoulos MA

    更新日期:2000-10-01 00:00:00

  • Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis.

    abstract:BACKGROUND:Sunitinib malate is an orally bioavailable tyrosine kinase inhibitor that is active against many tyrosine kinase receptors involving crucial pathways in both healthy tissues and malignant tissues. Because its use in clinical practice is quite recent, many of its possible side effects remain unknown. In this ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26435

    authors: Baldazzi V,Tassi R,Lapini A,Lunghi A,Garofoli E,Caruso S,Carini M,Mazzanti R

    更新日期:2012-06-15 00:00:00

  • HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

    abstract:BACKGROUND:Chronic myeloid leukemia (CML) may progress to blast phase (BP) at the rate of 1% to 1.5% per year. With the use of single-agent tyrosine kinase inhibitors, median overall survival ranges between 7 and 11 months. METHODS:The outcome was analyzed for 42 patients with lymphoid BP-CML who were treated with hyp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28433

    authors: Strati P,Kantarjian H,Thomas D,O'Brien S,Konoplev S,Jorgensen JL,Luthra R,Abruzzo L,Jabbour E,Quintas-Cardama A,Borthakur G,Faderl S,Ravandi F,Cortes J

    更新日期:2014-02-01 00:00:00

  • Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.

    abstract:BACKGROUND:It has been postulated that different biologic characteristics of a tumor might account for at least a portion of the disparity in breast cancer survival for patients across racial and ethnic groups. The hormone receptor status of breast tumors is one characteristic with prognostic significance. Results of s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CN

    authors: Gapstur SM,Dupuis J,Gann P,Collila S,Winchester DP

    更新日期:1996-04-15 00:00:00

  • Validation of the Edmonton Symptom Assessment Scale.

    abstract:BACKGROUND:The Edmonton Symptom Assessment Scale (ESAS) is a nine-item patient-rated symptom visual analogue scale developed for use in assessing the symptoms of patients receiving palliative care. The purpose of this study was to validate the ESAS in a different population of patients. METHODS:In this prospective stu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(20000501)88:9<2164::aid-cn

    authors: Chang VT,Hwang SS,Feuerman M

    更新日期:2000-05-01 00:00:00

  • Immunochemotherapy in human lung cancer using the streptococcal agent OK-432.

    abstract::Streptococcal agent OK-432 was administered at maintenance levels with conventional inductive chemotherapeutic agents to stage III and IV lung cancer patients. Survival rates were longer in patients treated with OK-432 than in patients treated without OK-432. An enhancement of lymphocyte blastogenic activity and a del...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197605)37:5<2201::aid-cncr282037

    authors: Kimura I,Ohnoshi T,Yasuhara S,Sugiyama M,Urabe Y

    更新日期:1976-05-01 00:00:00

  • Vitamin A, carotenoids, and retinoids.

    abstract::One promising area of current research in chemoprevention is the possibility that micronutrients, including vitamin A analogues, may decrease cancer incidence. The term "vitamin A" refers either to retinol (preformed vitamin A) and its synthetic analogues, or to certain carotenoids (provitamin A), which are converted ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19861015)58:8+<1837::aid-cncr282

    authors: Hennekens CH,Mayrent SL,Willett W

    更新日期:1986-10-15 00:00:00

  • Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.

    abstract:BACKGROUND:The authors suggested that the loss of collagen IV and laminin-containing basement membrane and the loss of Disabled-2 (Dab2) expression were two critical events associated with morphologic dysplastic changes of the ovarian surface epithelium as a step in tumorigenicity. Both the basement membrane and Dab2, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11847

    authors: Roland IH,Yang WL,Yang DH,Daly MB,Ozols RF,Hamilton TC,Lynch HT,Godwin AK,Xu XX

    更新日期:2003-12-15 00:00:00

  • Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.

    abstract::Sixty-four adult patients with refractory acute lymphocytic leukemia (ALL) received salvage therapy with the vincristine, doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH), and dexamethasone (VAD) regimen consisting of induction chemotherapy with the three agents followed by multiple-agent maintenance therapy...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890701)64:1<16::aid-cncr282064

    authors: Kantarjian HM,Walters RS,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1989-07-01 00:00:00